Evidence map›Paper›PMID 28553654›Full record

ArticleJournal of diabetes research2017

The

Thomas Albrecht, Shiqi Zhang, Jana D Braun, Li Xia, Angelica Rodriquez, Jiedong Qiu, Verena Peters, Claus P Schmitt, Jacob van den Born, Stephan J L Bakker and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. CNDP1 (CTG)Scientific reports · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  7. Serum Carnosinase-1 and Albuminuria Rather than theJournal of diabetes research · 2019
    Article
  8. Review
  9. Article
  10. Protective Actions of Anserine Under Diabetic Conditions.International journal of molecular sciences · 2018
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Thomas AlbrechtFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.ORCID 0000-0001-5543-1615
Shiqi ZhangFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Jana D BraunFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Li XiaFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Angelica RodriquezFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Jiedong QiuFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Verena PetersCentre for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
Claus P SchmittCentre for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
Jacob van den BornNephrology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Stephan J L BakkerNephrology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Alexander LammertFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Hannes KöppelFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Peter SchnuelleFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Bernhard K KrämerFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Benito A YardFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Sibylle J HauskeFifth Medical Department (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Heidelberg University · DEAnhui Medical University · CNUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering that the homozygous

Indexed as

AgedDiabetes Mellitus, Type 2Diabetic NephropathiesDipeptidasesFemaleGenetic Predisposition to DiseaseGenotypeHumansKidney Failure, ChronicMaleMiddle AgedPhenotypePolymorphism, GeneticRenal DialysisRetrospective StudiesTime FactorsCNDP1 protein, humanDipeptidases

Identifiers

PMID28553654
PMCPMC5434468
OpenAlexW2610628183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.